Product Details
Cefuroxime sodium
250/750/1500MG
Product Description :
CEFUROXIME SODIUM INJECTION
250 mg / 750 mg / 1500 mg
Sterile Powder for Solution for Intravenous or Intramuscular Administration
COMPOSITION
Each vial contains:
Cefuroxime Sodium equivalent to Cefuroxime ............... 250 mg
or
Cefuroxime Sodium equivalent to Cefuroxime ............... 750 mg
or
Cefuroxime Sodium equivalent to Cefuroxime ............... 1500 mg
Excipients: As applicable.
PHARMACEUTICAL FORM
Sterile, white to off-white powder for solution for intravenous or intramuscular administration.
THERAPEUTIC CLASS
Second-Generation Cephalosporin Antibiotic
INDICATIONS
Cefuroxime Sodium Injection is indicated for the treatment of infections caused by susceptible microorganisms.
It may be used in the treatment of:
• Lower respiratory tract infections
• Upper respiratory tract infections
• Urinary tract infections
• Skin and soft-tissue infections
• Bone and joint infections
• Intra-abdominal infections
• Gynecological infections
• Septicemia and bloodstream infections
• Perioperative prophylaxis against susceptible bacterial infections
• Other serious infections caused by susceptible bacteria
Treatment should be guided by the susceptibility of the causative organism and applicable antimicrobial guidelines.
CONTRAINDICATIONS
Cefuroxime Sodium is contraindicated in patients with known hypersensitivity to cefuroxime, other cephalosporins, penicillins, or any component of the formulation.
DRUG INTERACTIONS
Particular consideration may be required with concomitant use of:
• Probenecid
• Anticoagulants such as warfarin
• Aminoglycoside antibiotics
• Other nephrotoxic medicines
• Other β-lactam antibiotics
The treating physician should review all concomitant medications before administration.
ADMINISTRATION
Cefuroxime Sodium Injection may be administered by intravenous or intramuscular route according to the approved product information.
The contents of the vial should be reconstituted with a suitable compatible diluent under appropriate aseptic conditions.
For intravenous administration, the reconstituted solution should be further diluted as required and administered by a qualified healthcare professional according to the approved product information and institutional protocol.
For Intravenous or Intramuscular Use Only.
STORAGE
Store according to the storage conditions stated on the approved product label.
Protect from excessive heat, moisture and light.
After reconstitution/dilution, use within the period specified in the approved product information.